What is the balance of benefits and harms for lung cancer screening with low-dose computed tomography?

J R Soc Med. 2021 Apr;114(4):164-170. doi: 10.1177/0141076821991108. Epub 2021 Mar 10.

Authors

Stephen H Bradley¹, Bethany Shinkins², Martyn Pt Kennedy³

Affiliations

¹ Leeds Institute of Health Sciences, 4468University of Leeds, Leeds LS2 9JT, UK.
² Test Evaluation Group, Academic Unit of Health Economics, 4468University of Leeds, Leeds LS2 9JT, UK.
³ Department of Respiratory Medicine, 4472Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK.

No abstract available

MeSH terms

Aged
Cost-Benefit Analysis
Early Detection of Cancer / methods*
Europe
Female
Humans
Lung Neoplasms / diagnostic imaging*
Lung Neoplasms / mortality
Male
Mass Screening / methods*
Middle Aged
Patient Safety
Radiation Dosage
Randomized Controlled Trials as Topic
Smokers
Tomography, X-Ray Computed / methods*